Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and ...

Baxter International announced Monday that its CEO and board chair José Almeida is retiring, effective immediately – an ...

Vantive, formerly the Baxter Kidney Care segment, launched as a new standalone vital organ therapy company following the completion of its ...

Baxter President and CEO José Almeida has announced his retirement, effective immediately, after nearly a decade of leading ...

In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded ...

Baxter International Inc. , a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the ...

Concluding a two-year journey, Baxter International Inc.’s kidney care unit finally separated from the company and started a new life as Vantive, following the closing on Jan. 31 of its $3.8 billion ...

The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD 11,126.0 million in 2024 to an impressive USD 17,780.9 million by 2034. This ...

Baxter (BAX) announced that Jose Almeida, chair, president and CEO, will retire from his executive roles with the company, effective ...

Gifting allows recipients to access the article for free. On the heels of a major companywide restructuring, Baxter International told investors at the JP Morgan Healthcare Conference today that ...